Vistin Pharma ASA: Invitation to Q1 2026 conference call

17 Apr 2026 10:30 CEST

Oslo, Norway, 17 April 2026

Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 24th
of April 2026. Vistin Pharma will host a conference call for all shareholders
and interested parties on the same day at 08:30 CET. There will be a Q&A session
following the management discussion.

The first quarter conference call will be available via web and audio through
the following access points:

Webcast: https://edge.media-server.com/mmc/p/req62z7o

Telephone conference (online registration):

https://register-conf.media-
server.com/register/BIca3298faa94f4bbb900f07289bc40eb7

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)


About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.

More information:
Access the news on Oslo Bors NewsWeb site